FUJIFILM SECURES DIN-PACS IV CONTRACT FROM U.S. DEPARTMENT OF DEFENSE FUJIFILM SECURES Thursday August 24th, 2017By Tokio X'press JPN, medical service FUJIFILM SECURES
FUJIFILM INITIATES A PHASE I CLINICAL TRIAL OF ANTI-CANCER DRUG FF-10101 IN THE UNITED STATES IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA FUJIFILM INITIATES A PHASE Thursday August 10th, 2017By Tokio X'press medical service FUJIFILM INITIATES A PHASE
Japan 5-Year Cancer Survival Rate at 65.2 Pct . Japan 5-Year Wednesday August 9th, 2017By Tokio X'press medical service Japan 5-Year
第一三共、iPS細胞由来心筋シート商業化で大阪大学発ベンチャー企業へ出資 第一三共、iPS細胞由来心筋シート商業化で Monday August 7th, 2017By Tokio X'press IPS, medical service 第一三共、iPS細胞由来心筋シート商業化で
日本企業、幹細胞で血液凝固に必要な成分の大量生産に着手 日本企業は幹細胞で血液凝固に必要な成分の大量生産に着手 Monday August 7th, 2017By Tokio X'press disease 日本企業は幹細胞で血液凝固に必要な成分の大量生産に着手